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Background: Transient early-life perturbations in glucocorticoids (GC) are linked with cardiovascular
disease risk in later life. Here the impact of early life manipulations of GC on adult heart structure,
function and gene expression were assessed.
Methods and results: Zebrafish embryos were incubated in dexamethasone (Dex) or injected with tar-
geted glucocorticoid receptor (GR) morpholino knockdown (GR Mo) over the first 120 h post fertilisation
(hpf); surviving embryos (>90%) were maintained until adulthood under normal conditions. Cardiac
function, heart histology and cardiac genes were assessed in embryonic (120 hpf) and adult (120 days
post fertilisation (dpf)) hearts.
GR Mo embryos (120 hpf) had smaller hearts with fewer cardiomyocytes, less mature striation pattern,
reduced cardiac function and reduced levels of vmhc and igfmRNA compared with controls. GR Mo adult
hearts were smaller with diminished trabecular network pattern, reduced expression of vmhc and
altered echocardiographic Doppler flow compared to controls. Dex embryos had larger hearts at 120 hpf
(Dex 107.2 ± 3.1 vs. controls 90.2 ± 1.1 mm, p < 0.001) with a more mature trabecular network and larger
cardiomyocytes (1.62 ± 0.13 cells/mm vs control 2.18 ± 0.13 cells/mm, p < 0.05) and enhanced cardiac
performance compared to controls. Adult hearts were larger (1.02 ± 0.07 mg/mg vs controls
0.63 ± 0.06 mg/mg, p ¼ 0.0007), had increased vmhc and gr mRNA levels.
Conclusion: Perturbations in GR activity during embryonic development results in short and long-term
alterations in the heart.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY
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Epidemiological studies in humans indicate that prenatal
glucocorticoid (GC) excess is associated with increased risk of
cardio-metabolic disease in later life (Seckl and Meaney, 2004).
Rodents exposed to excess GCs during foetal life are more likely to
be hypertensive, obese and display impaired glucose tolerance as
adults (Nyirenda et al., 1998). While these observations suggest a
link between transient changes in early life GCs and cardiovascular
risk factors it remains unclear whether this risk also includes
changes in the structure and function of the heart itself.
Recent work has supported a link between reduced GC receptor
(GR) signalling during early life and altered structure and function
of the foetal heart. Global GR null mice (GR/), at embryonic day
(E) 17.5, have smaller hearts with altered contractility, myofibrillar
patterning and expression of calcium handling genes. These mices article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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have not been studied. Mice with cardiomyocyte/vascular smooth
muscle cell specific disruption of GR (SMGRKO mice) however do
survive into adulthood and these have larger hearts with evidence
of fibrosis and impaired contractility (Richardson et al., 2013).
Genetic knockout models result in long-term reductions in
endogenous GR signalling which, while interesting and important,
are unable to address the impact of short term changes in signalling
during embryonic development. Models of GC excess typically
involve treatment of pregnant rats and sheep with synthetic GC;
have addressed the impact of increased exogenous GR signalling
during foetal development. These latter models are confounded by
GC-induced changes in the maternal hypothalamic-pituitary-
adrenal (HPA) axis. They are also unable to address both an in-
crease and a decrease in GR signalling in a contemporaneous
experiment using animals with similar genetic background main-
tained in identical environmental conditions.
The zebrafish circumvents the problems of maternal or
placental effects on the developing cardiovascular system, allowing
investigation of direct effects of GCs on the developing embryo. In
addition, the zebrafish exhibits very similar GC metabolism to
mammals, with many key enzymes and pathway products of ste-
roidogenesis similar to those observed in humans (Schoonheim
et al., 2010), including the predominance of cortisol as the main
circulating corticosteroid. This system, referred to as the
hypothalamus-pituitary-interrenal (HPI) axis in teleost fish, is
analogous to themammalian HPA axis (Alsop and Vijayan, 2008). In
addition, the zebrafish GR gene (gr), of which there is only one
version, is remarkably similar in structure to the human form (GR)
(Aluru and Vijayan, 2009). The zebrafish GR has garnered
increasing interest with a number of publications highlighting the
importance of this receptor in development (Hillegass et al., 2007;
Kondo, 2007; Nesan et al., 2012; Nesan and Vijayan, 2013a;
Pikulkaew et al., 2011). However little is known about the effects
of transient disruption of GC signalling in early development and
even less is known about the long-term effects into adulthood.
While multiple methods exist to allow disruption of GC one key
technique used in this study is morpholino (Mo) knockdown tar-
geted at the GC receptor (gr) gene. This technology has been used
extensively by developmental biologists in the zebrafish. However,
its use as an approach to create a temporary or short-term knock-
down of gene activity, in this case the gr, and subsequent long term
study of organ structure and function has not been previously
reported.
In the work presented here we address the hypothesis that even
modest changes in GC activity, either through excessive GC expo-
sure, or reduced GC action, during embryonic development would
result in short and long-term effects on the structure and function
of the heart. Furthermore, we predicted that these findings would
be accompanied by changes in molecular pathways known to in-
fluence function and structure of the heart which may in turn
impact on its ability to respond to increased work load, stress or
injury.
2. Methods
2.1. Zebrafish husbandry
All animal experimentation was carried out in accordance with
the accepted standards of humane animal care under the regulation
of the Animal (scientific procedures) Act UK 1986, following
experimental approval by the University of Edinburgh animal
ethics committee.
Zebrafish transgenic cardiac myosin light chain two: green
fluorescent protein (Tg (CMLC2:GFP)) fish were used throughoutthis study and were housed in 10 L tanks (3 fish/L) and maintained
under standard conditions (14:10 h light: dark photoperiod, at
ambient temperature of 28.5 C (Kimmel et al., 1995). Eggs were
collected and stored in “systems water” comprising 6 g salt (Tropic
Marin® Wartenberg, Germany) and 0.5 mg/L of the antiseptic
methylthioninium chloride (methylene blue) in 20 L of in-house
deionised H2O. All fertilised age-appropriate eggs (2 cell stage
(~1 h post fertilisation (hpf)) (Kimmel et al., 1995) were either
injected with Mo (or control) or treated with drug (or vehicle) and
housed in 10 cm petri dishes at 28.5 C. Batches of embryos that had
undergone GC manipulation during the first 120 hpf were allowed
to grow until adulthood (120 days post fertilisation -dpf) under
normal husbandry conditions. These fish were closely monitored
for distress or structural abnormalities throughout their growth
and showed no significant excess of morbidity or mortality
compared to controls.
2.2. Embryonic GR manipulation
Mo were obtained from GeneTools (Philomath, Oregon, USA) to
down-regulate the zebrafish GR gene (gr). As the primary aim of
this study was to determine the long-term effects of transient
knock down in Gr protein in the zebrafish heart a start site tar-
geted Mo (ATG Mo) was designed, this Mo is targeted to the 50
untranslated region (50 UTR) of the mRNA encoding Gr protein
(ATG Mo- cattctccagtcctccttgatccat) to prevent the transcription of
the Gr protein. The use of an ATG Mo is a convenient means of
knocking down expression of the protein and learning how that
knockdown changes the cells or organism. As knockdown with
and ATG Mo prevents the translation of the coding region of the
targeted transcript confirmation of ATG Mo success was carried
out by western blot analysis of the total Gr protein (see western
blot analysis). As a control for the ATG Mo a 5 bp mispair Mo was
designed (Mism Mo- cattgtccactcctgcttcatcgat). Each Mo incor-
porated a red emitting fluorescent tag to confirm integration
throughout the developing embryo. Microinjection of Mo was
performed at the 2-cell stage using a standard approach (Nusslein-
Volhard and Dahm, 2002) with a IM-300 Narishige programmable
micro-injector. Volume of Mo injected was calculated by
measuring the droplet radius (bolus volume ¼ 4/3 pr3). Careful
titration studies were performed to select a concentration of Mo
which avoided off-target, non-specific developmental abnormal-
ities while also producing consistent modest knockdown of Gr
protein levels, the concentration selected for was 3 ng/nL. The
120 hpf survival of this group 78.25 ± 1.11% vs Mism Mo
84.00 ± 1.47%, p ¼ 0.02.
To create excess exogenous GR signalling during early life,
embryos (between 24 and 120 hpf) were exposed to the syn-
thetic GR agonist dexamethasone (Dex) in the bathing water. This
was dissolved in ethanol and added to the systems water from 24
to 120 hpf. Systems water containing vehicle [0.1% total volume
ethanol] was included as experimental control. Solutions were
replaced every 48 h. A Dex dose-range study (1e200 mM) was
undertaken as part of a series of separate experiments to
establish an optimal concentration of 100 mM (Wilson et al.,
2013). Briefly, the Dex concentration range was selected based
on published pharmacological data, while the upper limit may
appear relatively high in comparison to mammalian studies,
these concentrations were selected based on previous zebrafish
publications (Hillegass et al., 2007; Schaaf et al., 2008).
Furthermore the selected concentration was chosen as it signif-
icantly altered physiology (Wilson et al., 2013) but did not impact
on survival (Dex 87.33 ± 0.88% vs vehicle only controls
93.00 ± 2.08%, p ¼ 0.06) or gross morphology (Wilson et al.,
2013).
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Batches of embryos that had undergone GC manipulation as
outlined above, with either GR Mo (ATG Mo) or Dex, and displayed
no significant structural or phenotypic abnormalities as recom-
mended by Home Office veterinary officers, were allowed to grow
until adulthood (120 dpf) under normal husbandry conditions (as
detailed in husbandry section). These adult fish were closely
monitored for distress or structural abnormalities throughout their
growth until 120 days.
2.4. Functional assessment of embryonic hearts
The functional impact of GR modulation was assessed using Tg
(CMLC2: GFP) zebrafish embryo hearts visualised using an Axi-
oskop II MOTcompoundmicroscopewith a (40) dipper objective
lens. Videos and still frame images were captured using a black
and white camera and analysis was carried out via attached PC.
Ventricle length, width, area and volumewere assessed in diastole
and systole for three cardiac cycles using image analysis software
(ImageJ). Ventricle area was measured assuming the ventricle was
elliptical in shape and using the equation (area ¼ p ab (where a is
half the long axis length and b is half the short axis length)) were
assessed in diastole and systole for three cardiac cycles using
image analysis software (ImageJ). Heart rate was assessed from
these captured images over 3 cardiac cycles using frame rate (30/
second) as the unit of time. Stroke volume was assessed by
measuring ventricle diastolic and systolic area and then assuming
the ventricle was ellipse shape. The volume change during the
cardiac cycle was estimated from the formula volume ¼ 4/3 p abc
(where a and b are described above and c is half the depth in the z-
plain). Cardiac output was estimated as the product of the stroke
volume and heart rate for each heart. Ejection fraction was esti-
mated as percentage area change between diastole and systole
using the formula (diastolic area-systolic area) ÷ diastolic area,
expressed as a percentage.
2.5. Echocardiography of adult hearts
Adult heart functional assessment was carried out by ultra-
sound (VisualSonics, Vevo 770). Zebrafish were anaesthetised us-
ing MS222 and placed on their dorsal surface in a shallow bath
containing induction strength MS222 (4.2%) and gently restrained
using a Plastiscine mould. A RMV 711, central frequency 55 MHz
transducer was used to acquire B-mode and spectral Doppler
images in transverse and longitudinal planes of the ventricular
inflow and outflow signals. Images were captured representing
5e10 typical cardiac cycles and analysed by a single experienced
operator (AT). B-mode images were analysed for area change of
the ventricle during the cardiac cycle in the long axis view and
Doppler signals were analysed for peak in-flow and out-flow ve-
locities and for associated acceleration and deceleration values
and times.
2.6. Embryonic heart histology
Heart ventricles from embryos (120 hpf) were isolated and
stained with DAPI (nuclear stain). These were then mounted in
ProLong antifade mounting agent (Life technologies) and detailed
images obtained using a confocal microscope. Cardiomyocytes
were counted in each ventricle using a previously validated tech-
nique (Matrone et al., 2013) from Z-stacks in 3 mm sections moving
progressively through the ventricle counting nuclei which clearly
overlapped with GFP signal.2.7. Adult heart histology
Histology was performed on adult hearts using a protocol pre-
viously published (Sabaliauskas et al., 2006). Briefly, isolated hearts
were fixed in 4% paraformaldehyde (PFA) overnight then washed 3
times with 1 X phosphate buffered saline (PBS). Hearts were stored
in methanol until embedding in 2% agarose which were subse-
quently paraffin embedded. These paraffin blocks were then
microtome sectioned into 5 mM thin sections onto microscope
slides. After drying sections were stained with haematoxylin and
eosin (H&E) staining was performed using a standard protocol
(Fischer et al., 2008). Ventricle Cavity Area was assessed quantita-
tively using ImageJ on H&E stained sections, where ventricle size
was calculated by tracing around the outer ventricular wall using
the free-hand tool, inter-trabecular space was then determined by
tracing around areas of free-space (unstained with no apparent
tissue) within this ventricle. The regions of empty space were then
totalled to give the free area within the section. This inter-
trabecular space was then subtracted from the total ventricular
area and the total percentage of inter-trabecular was thus given as a
percentage. This was carried out on a minimum of 6  5 mM sec-
tions per heart and for 8 hearts from each treatment group.2.8. Heart isolation for RNA extraction
Embryonic hearts were isolated using a previously published
method utilising mechanical agitation(Burns and MacRae, 2006).
Briefly, embryos were pooled in a 1.5 ml Eppendorf tube and a 19
gauge needle with regular bevel attached to a 5 ml syringe was
inserted and repeatedly plunged (30e40 times) to homogenise
the embryos. The resulting homogenate was filtered through a
105 mm nylon mesh, the perfusate was collected and GFP positive
hearts were selected under fluorescent microscope. Isolated
hearts were stored in RNAlater for qRT-PCR. Adult fish were
culled by anaesthetic overdose (MS-222) and hearts removed by
surgical dissection and placed in a small volume of RNAlater
solution.2.8.1. RNA extraction and qRT-PCR
Total RNA was extracted from pools of isolated embryonic
hearts (120 hpf, 150 hearts per sample) or pooled adult hearts (5
hearts per sample) after initial homogenisation using a bead
mixer mill (3 min 15 Hz) using the RNeasy Mini kit (Qiagen) ac-
cording to manufactures instructions. Following this, DNA-free™
kit (Applied Biosystems, Warrington, UK) was used to eliminate
possible gDNA presence. RNA quantity was determined using a
Nanodrop® spectrophotometer ND-1000 (Fisher Scientific,
Loughborough, UK) to determine extracted RNA concentration at
260 nm (extinction coefficient 40 ng/mL). RNA integrity was
verified by a 260/280 nm absorbance ratio of ~2 and 1% agarose
gel electrophoresis.
Total RNAwas reverse transcribed using the High capacity cDNA
Reverse Transcription Kit (Applied Biosystems, Warrington, UK)
according to manufacturer's guidelines. qRT-PCR was performed to
quantify the expression of a number of gene mRNA (for sequences
see supplemental Table 1) using the LightCycler 480 system (Roche,
Hertfordshire, UK) with universal probes library (UPL) probes
(Roche Diagnostics Ltd, UK) at the standard operating conditions
95 C for 5 min, 50 cycles (95 C 10 s, 60 C 30 s, 72 C 1 s), 40 C
30 s). For each experiment an appropriate housekeeping gene was
run concurrently which enabled gene of interest quantification
using the LightCycler software, data produced is throughmaximum
second derivative method, whereby the entire amplification curve
is considered rather than just the threshold point.
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Protein was obtained from pooled embryonic (150 hearts) or
adult hearts (10 hearts) or pooledwhole embryos (10 embryos) by a
standard protocol. Pooled hearts were covered in radio-
immunoprecipitation assay (RIPA) buffer 50 mL (containing phe-
nylmethylsulfonyl fluoride (1 mM) and protease inhibitors [1:100]
(SigmaeAldrich protease inhibitor cocktail P2714: AEBSF 2 mM,
E64 14 mM, Bestatin 130 mM, Leupeptin 0.9 mM, Aprotinin 0.3 mM,
EDTA 1 mM) and homogenised in a Soniprep Ultrasonic Homoge-
nizer (Sonciator e Model 3000 MP Ultrasonic Homogenizer, Bi-
oLogics). Samples were run as per manufacturer's instructions,
with SDS Bis-Tris buffer at 100 V for 45 min. The gel was then
transferred to nitrocellulose membrane by a semi-dry transfer
method (200 mA for 120 min) using transfer buffer (Tris base, pH
8.3, 25 mM, glycine 192 mM, methanol 20%). Membranes were
blocked and probed following a standard western blotting tech-
nique. Primary antibody used in this work was a GR antibody
(1:100 dilution of a goat anti-trout GR) which was a kind gift from
Dr M Vijayan, University of Waterloo, Canada (Pikulkaew et al.,
2011).The secondary used was a rabbit anti goat antibody conju-
gated to horse radish peroxidase (HRP) (1:1000) (Santa Cruz
Biotechnology, Heidelberg, Germany, Cat no sc-2768) allowing
detection by enhanced chemiluminescence (ECL) reagent (GE
Healthcare, Buckinghamshire, UK).2.10. GR morpholino rescue
To determine whether the effects observed for the GR Mo were
due specifically to Gr knock-down or due to non-specific effects a
rescue experiment was carried out using a modified 50-UTR
zebrafish gr mRNA (gr-RNA). As the rescue has a modified 50UTR it
contains no target for the ATG Mo but the coding region of the
rescue contains the sequence to encode the protein of interest.Fig. 1. Manipulation of glucocorticoid activity induces changes in cardiac structure Confocal
after 120 h glucocorticoid receptor (GR) manipulation with either GR agonist dexametha
mounted GFP embryonic hearts (green) were stained with DAPI (blue) and imaged at h
at 20 magnification, higher power images (40 magnification) demonstrate advanced matu
immaturity of myofibrillar and trabecular patterning. (For interpretation of the references tTemplate DNA was obtained in the form of IMAGE clone (Source
Bioscience, Cambridge), in purified plasmid Miniprep form. The gr
gene was cloned into the pNR-LIB clone (Source Bioscience, Cam-
bridge) and linearized using XhoI restriction enzyme (Applied
Biosystems). Capped transcription reaction was carried out using
the mMessage mMachine Kit (Ambion) according to manufac-
turer's instruction. Final capped mRNA concentration was achieved
by dilution in sterile RNAse free dH20.
2.11. Statistical analysis
Experiments were performed triplicate with on average 20e30
larvae per experiment, unless otherwise stated. Data are mostly
presented as mean ± standard error of the mean (SEM) unless
otherwise stated. Statistical analyses were performed using
GraphPad Prism 5. One-way or two-way repeated measures anal-
ysis of variance (ANOVA) followed by Bonferroni or Dunnett's post-
hoc tests were used to compare means within and between groups.
P values < 0.05 were considered significant.
Data for control groups are presented in most figures as a
combined mean value following detailed analysis comparing the
control groups, there was no significant difference between the
control-Dex and control-Mo embryo data for a wide range of
measured parameters (Supplemental Table 1). Statistical differ-
ences stated for the treatment groups however were between
treatment and their specific control group.
3. Results
3.1. Glucocorticoid manipulation impacts on structure and function
of the embryonic heart
In contrast to control (age-matched and untreated) hearts at
120 hpf, which displayed a clear striation pattern with a matureimages of embryonic (120 h post fertilization (hpf)) of Tg (CMLC2: GFP) zebrafish hearts
sone, (Dex) [100 mM] or targeted GR knockdown using morpholino (GR Mo). Whole
igh power with a confocal microscope. Gross cardiac morphology can be observed
rity of the Dex treated hearts in contrast to the GR Mo hearts which show considerable
o colour in this figure legend, the reader is referred to the web version of this article.)
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smaller with a less well developed trabecular network and absent
striations. Dex treated hearts, in contrast to the GR Mo hearts,
showed amature trabecular networkwith well-developed striation
patterns.
Ventricle inflow: outflow distance (IOD), a measure of the de-
gree of cardiac looping during development, was increased at
72 hpf in GR Mo treated embryos suggesting delayed heart devel-
opment (Fig. 2A). Ventricles from GR Mo treated embryos showed
reduced cross-sectional area compared to controls (Fig. 2B) and
reduced number of ventricular cardiomyocytes per unit heart vol-
ume (Fig. 2C). Heart rate and cardiac output were reduced in GRMo
embryos (Fig. 2D and F). In Dex-treated embryos, ventricle inflow:
outflow distance was not different from controls (Fig. 2A), cross-
sectional area was increased (Fig. 2B) and number of car-
diomyocytes per unit heart volume was reduced compared to
controls (Fig. 2C). Dex-treated embryos had similar heart rates but
greater stroke volume and greater cardiac output compared to
controls (Fig. 2DeF).
Isolated hearts from GR Mo embryos (120 hpf) were confirmed
to have lower Gr protein abundance than controls, (18.60 ± 4.45%
reduction compared to age matched controls p < 0.05. By adult-
hood however (120 dpf) there was no difference in heart Gr protein
in GR Mo adults compared to controls confirming the transient
nature of this genetically induced reduction in GR activity (Fig. 3A
and B). In contrast hearts isolated from embryos treated with Dex
showed no significant alteration in Gr abundance compared to
controls at either 120 hpf or 120 dpf (Fig. 3A and B).The effects of GR
Mo on heart size, cardiomyocyte number and total embryo protein
expression were partially rescued by co-treatment with a gr-RNA
(rescue), with heart size and cardiomyocyte number both greater
than GR Mo alone, but still reduced compared to mism controls
(Fig. 3C and D). In contrast to control isolated hearts (120 hpf), aFig. 2. Effects of glucocorticoid manipulation on development, structure and function of t
carried over 120 h post fertilization (hpf) using Tg (CMLC2:GFP) zebrafish which had been e
120 h or treated with targeted GR translational blocking morpholino (GR Mo). Results were
(mism Mo) controls. Parameters investigated were A) Inflow/outflow area (measured at 7
ventricular area, a marker of cardiac growth and development, C) cardiomyocyte number no
mean ± SEM and were compared to control by one-way ANOVA and Dunnett's post hoc test
(6 hearts per experiment) ± SEM *P  0.05, **P  0.001, C) ventricle cardiomyocyte numb
function assessments n ¼ 4 experiments (12 embryos per experiment) *p  0.05.lack of clear striation pattern was observed in GR Mo embryo
hearts, however striation was observed in hearts isolated from
embryos co-treated with GR Mo and gr-RNA (Fig. 3E).
3.2. Glucocorticoid manipulation impacts on gene expression in the
larval heart
Genes associated with growth and maturity (igf, mef2c and
vmhc) were affected by GR manipulation in isolated embryonic
(120 hpf) hearts (Fig. 4). No alteration in expression was observed
for gr mRNA in either the Dex or GR Mo groups (Fig. 4A). Isolated
hearts fromGRMo embryos however displayed reduced expression
of vmhc and igf mRNA; in contrast Dex-treated embryos showed
increased levels of vmhc and igf compared to controls (Fig. 4B and
C). Phospholamban (plb) mRNA expression was found to be
decreased in hearts isolated from Dex-treated embryos compared
to their controls (Fig. 4D) however no change was noted in these
hearts for other genes associated with calcium handling (sarco-
endoplasmic reticulum calcium transport ATPase (serca) the rya-
nodine release channel gene (ryr) (Fig. 4E and F). While the ryr
expressionwas lower in GR Mo embryos there was no difference in
other genes associated with calcium handling proteins (Fig. 4DeF).
mef2c expression was found to be lower in hearts isolated from GR
Mo compared to controls, Dex-treatment had no impact on the
expression of this gene (Fig. 4G). Neither GR Mo nor Dex treatment
were found to alter the expression of gata4 or nkx2.5 (Fig. 4H and I).
3.3. Transient early-life glucocorticoid manipulation impacts on
structure, function and gene expression in the adult heart
Adult zebrafish hearts (Fig. 5) derived from GR Mo embryos
were shorter in length (normalised to total fish length (Fig. 5A) and
weighed less (normalised to body weight (Fig. 5B) compared tohe embryonic heart Structural and functional observations of embryonic hearts were
xposed to the glucocorticoid receptor (GR) agonist dexamethasone (Dex) [100 mM] for
compared with controls which are a mean of Dex (vehicle only) controls and GR Mo
2 hpf), an indicator of cardiac looping from cardiac tube to two chambered heart, B)
rmalized to heart length, D) heart rate, E) stroke volume and F) cardiac output. Data are
. A) inflow/outflow distance n¼ (20 ***p  0.0001, B) ventricle area n ¼ 4 experiments,
er (normalized to body length) n ¼ 12 hearts *p  0.05, **p  0.01. DeF), all cardiac
Fig. 3. Effects of glucocorticoid receptor morpholino and rescue on the embryonic heart Western blot analysis was carried out to determine whether glucocorticoid receptor protein
(Gr) was reduced in isolated hearts from zebrafish embryos (5 days post fertilization (5 dpf)) or adults (120 dpf) which had been treated with either glucocorticoid receptor (GR)
translational blocking morpholino (GR Mo) or with GR agonist dexamethasone (Dex) [100 mM] for 120 h (5 dpf). A) Densitometry of Western blots of Gr abundance in isolated
hearts. Data are n ¼ 3 (150 embryo heart or 10 adult hearts per n), given as a mean percentage of their respective controls (mism Mo for GR Mo and vehicle for Dex) ± SEM analysed
by two-way ANOVA and Bonferroni post hoc test. *p  0.05. B) Example of Western blot of embryonic (5 dfp) and adult (120 dpf) heart tissue lysates probed with antibodies against
Gr with alpha-tubulin (loading control), C) Success of GR Mo was further determined following co-injection of rescue mRNAwith GR Mo and calculation of ventricle length at 120 h
post fertilization (hpf) D) Calculation of cardiomyocyte number at 120 hpf. C and D) n ¼ 3 (6 embryos per group). Data are mean ± SEM analysed by two-way ANOVA and Bonferroni
post hoc test vs each individual group. *p  0.05 and **p  0.01. E) Densitometry of Western blots of Gr abundance in 120 hpf whole embryo homogenate. Data are n ¼ 3 (10 embryo
per n), data given as relative protein abundance for control (mism Mo), GR Mo, and Gr mRNA rescue (rescue) n ¼ 3 mean ± SEM analysed by two-way ANOVA and Bonferroni post
hoc test, *p  0.05, **p  0.01. F) Confocal images of isolated 120 hpf Tg (CMLC2: GFP) zebrafish hearts (green) co-stained with DAPI nuclear stain (blue), images are isolated from
embryos which were treated with control morpholino (mism Mo), GR Mo and capped GR mRNA (rescue) co-injected with GR Mo. (For interpretation of the references to colour in
this figure legend, the reader is referred to the web version of this article.)
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more sparse trabecular network (Fig. 5F compared to controls
Fig. 5D) which when quantified resulted in an increased ventricle
cavity area (Fig. 5C). Adult hearts derived from Dex-treated em-
bryos were heavier with similar length and trabecular pattern
compared to controls (Figures AeC); histologically they were
similar to controls (Fig. 5D and E).
Echocardiography (Fig. 6) indicated that adult hearts derived
from GR Mo embryos had similar heart rate (Fig. 6C), ejection
fraction (Fig. 6D) and end diastolic area (Fig. 6E) however hadreduced ventricular inflow velocity (Fig. 6F), inflow deceleration
time (Fig. 6G) and velocity time integral (Fig. 6H) compared to
controls. Dex-treated adult hearts had similar ejection fraction and
Doppler signals compared to controls (Fig. 6BeG).
Ventricles from adults treated with Dex during embryonic
development had increased expression of gr, vmhc and plb mRNA
compared to controls (Fig. 7A, C and D respectively) but displayed
reduced mef2c and ryr mRNA relative abundance compared to
controls (Fig. 7I and G respectively). In adult ventricles derived from
GR Mo embryos, mRNA levels of vmhc (Fig. 7C) and gata4 (Fig. 7H)
Fig. 4. Effects of glucocorticoid manipulation on embryonic heart genes Relative mRNA abundance was determined in isolated hearts at 120 h post fertilization (hpf) after 120 h
glucocorticoid receptor (GR) manipulation with either dexamethasone (Dex) [100 mM] or targeted gr morpholino (GR Mo). Genes which were investigated were (A) Glucocorticoid
receptor (gr) (B) Insulin like growth factor (igf) (C) ventricular myosin heavy chain (vmhc) (D) phospholamban (plb) (E) Ryanadine receptor (ryr) (F) sarco-endoplasmic reticulum
Ca2þ ATPase (serca) (G) myocyte enhancer factor 2 c (mef2c) (H) GATA transcription factor 4 (gata4) and (I) Homeobox protein NKX2.5 (nkx2.5). mRNA expression was determined
from isolated hearts at 120 hpf normalized to house-keeping gene, data are mean of n ¼ 3 (150 hearts per n) ± SEM *p  0.05, **p  0.01. All data were compared to their controls by
one-way ANOVA and Dunnett's post hoc test.
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abundancewas increased (Fig. 7D and G respectively). No alteration
in gene abundance was observed for igf and nkx2.5 in either GR Mo
or Dex treated embryos (Fig. 7B and I).
4. Discussion
Polymorphisms in GC receptors have been well described in the
literature and these have been associated with variations in human
response to stress, injury and disease (Quax et al., 2013). The rele-
vance of the study reported here is therefore clear, subtle and
transient increases or decreases in GR activity during the life cycle
of an organism, particularly during embryogenesis and early
development, can have significant long-term effects on the struc-
ture and function of a number of GR-sensitive organs and systems
including the heart.
Our study has clearly shown that changes in GR signalling
during early life can cause long-term alterations in the structure,
function and gene expression of the adult heart. The approach of
studying both increased and decreased activity of GR in the same
model contemporaneously has allowed us to directly compare and
contrast the actions of GCs on the embryonic and adult heart.4.1. Diminished GR activity during embryogenesis delays cardiac
development and leads to altered cardiac structure and function in
adult life
Our findings, using GR Mo knockdown in the teleost fish, are
consistent with those described in the (GR /) foetal mouse (Rog-
Zielinska et al., 2012) where hearts were smaller, with reduced
cardiomyocyte size and greater cardiomyocyte density (Richardson
et al., 2013). In-utero echocardiography of these foetal hearts
showed altered Doppler signals suggestive of impaired cardiac
function although, unlike the GR Mo zebrafish embryos, they had
normal ejection fraction. Similar to the mouse (GR/), GR Mo
zebrafish embryos (at 120 hpf) displayed changes in expression of
key cardiac genes. Alterations in cardiac developmental genes in
whole GR Mo treated embryos has been reported previously, using
microarray techniques (Nesan and Vijayan, 2013b), The findings
reported here are concordant with this study although we have
further refined the approach by demonstrating gene changes in
isolated embryonic hearts. Together however, these studies un-
derscore the critical role of GC signalling in programming molec-
ular events essential for zebrafish heart development. In particular
the observed changes in the mRNA of endoplasmic calcium release
Fig. 5. Effects of embryonic glucocorticoid manipulation on adult heart structure Long-term impact of embryonic glucocorticoid receptor (GR) manipulation with either GR agonist
dexamethasone (Dex) [100 mM], or targeted translational GR knockdown using morpholino (GR Mo) was assessed in the heart of 120 day post fertilisation (dpf) adult zebrafish.
Structural analyses of A) ventricle length, B) weight and C) cavity area were carried out. Data are n ¼ 8 hearts per group, displayed as mean ± SEM analysed by one-way ANOVAwith
Dunnett's post hoc comparison (*p < 0.05, **p < 0.01, ***p < 0.001). DeF) Histology (haematoxylin and eosin staining) in adult fish hearts D) Controls (Vehicle only control shown
here), E) Dex, F) GR Mo.
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derm from 14 hpf, is known to play a dual role in contractile
function and cardiac development (Wu et al., 2011). Its reduced
expression in our GR Mo embryos may therefore account for
changes in both development and cardiac contractility in embry-
onic hearts. Reduced cardiac function in these embryos could also
be partly due to a loss of the direct inotropic effects of GCsmediated
by a reduction in GR. A direct inotropic effect of GCs has been
described in rodent models (Richardson et al., 2013) but not pre-
viously in the embryonic zebrafish heart.
One key difference between the experiments described here
and the studies in the GR/ mouse is the transient nature of the
Mo knockdown and the subsequent survival of the majority of
embryos into adult life. Survival to 120 hpf following GR Mo
treatment was similar in this study to previous studies using this
(Pikulkaew et al., 2011), and similar to studies treating embryos
with glucocorticoids (Nesan et al., 2012). A high level of survival of
apparently healthy embryos to the 5 day time point was important
in our study for three reasons; firstly, we did not want to produce
large numbers of embryos with developmental or structural ab-
normalities which would then limit their chances of survival to
adulthood. This had the potential to create survival-bias which
could have influenced our findings. Secondly, from an ethical
viewpoint, we did not want to have fish with structural abnor-
malities to develop into adulthood with the potential suffering.Thirdly, the aim of our underlying hypothesis was to assess the
more subtle effects of GC manipulation during early development
possibly mimicking those that might occur in settings where
polymorphisms of the PR receptor could influence their action on
the developing heart. By adopting this novel experimental
approach we observed adult hearts, derived from GR Mo treated
embryos that were significantly smaller than controls with poorly
developed trabecular network and reduced thickness of compact
myocardium. The level of knockdown of Gr was around 30% at
120 hpf, by adulthood however, there was restoration of Gr protein
levels to normal. This return of Gr expression by 120 dpf was clearly
unable to restore normal cardiac structure and function. Indeed the
histological appearance of GR Mo adult hearts was more similar to
those of a normal juvenile heart at 40 dpf (Gupta et al., 2013).
The lack of maturity of GR Mo hearts is reflected in the lower
expression of vmhc mRNA which also could have impacted on
cardiac contractility. The increase in plb gene expression might also
be predicted to reduce sarcoplasmic reticulum calcium uptake
leading to altered cardiac diastolic function. However, the most
striking difference in cardiac gene expression observed in these
hearts was the reduction in gata4 and an increase in mef2c abun-
dance. Both of these genes are linked with early proliferative pro-
cesses in the heart and the reduction in gata4 could therefore
account for the smaller number of cardiomyocytes detected in the
GR Mo embryonic hearts. Increased mef2c may reflect the
Fig. 6. Effects of embryonic glucocorticoid receptor manipulation on adult cardiac function Echocardiography was used to assess function of the adult ventricle using standard B-
mode techniques and inflow and outflow Doppler patterns of the ventricle. A) Show typical examples of B-mode images used for calculation of ejection fraction using the epicardial
outline in systole and diastole. B) Doppler signals obtained in the transverse plain were used to capture inflow and outflow velocity envelopes. Analysis of all images was undertaken
by an independent operator blinded to treatment of the zebrafish. From echocardiography a number of cardiac functional parameters were determined following manipulation of
glucocorticoid receptor (GR) such as C) heart rate, D) ejection fraction, E) end diastolic area, F) inflowmean velocity, G) inflow deceleration and H) inflow velocity time integral (vti).
Data presented are for adults treated with 100 mM dexamethasone (Dex) as embryos n ¼ 10, those treated with morpholino targeted towards Gr (GR Mo) n ¼ 10, and Controls n ¼ 17
(consisting of Dex controls n ¼ 9 and GR Mo controls n ¼ 8) and displayed as mean ± SEM. Data were analysed by one-way ANOVA and Dunnett's post hoc test, (*p < 0.05 and
**p < 0.01).
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mechanisms attempting to compensate for reduced cardiac func-
tion. Taken together, this combination of altered structure and
expression of important contractile and cardiac genes might be
expected to impair cardiac performance as confirmed by echocar-
diographic Doppler indices demonstrating ventricular inflow sig-
nals consistent with increased ventricle stiffness.
The effects of GR Mo treatment may have been partly related to
overall developmental delay. However, a direct impact on matu-
ration and development of the cardiovascular system is also likely.
Indeed, altered cardiomyocyte number and abnormal sarcomere
patterning observed in GR Mo embryos, were rescued by gr mRNA
lending support for a key role played by GCs in cardiomyocyte
proliferation and function.4.2. Increased glucocorticoid action during embryogenesis
accelerates maturation of the embryonic heart
Exposure to excess synthetic corticosteroids during foetal life
has been extensively studied in mammalian models including rats,
mice and sheep (Fowden and Forhead, 2004; Nyirenda et al., 1998).
These have been considered as classical models of foetal pro-
gramming. There have been no similar studies using short-termexposure in zebrafish until now. One particular advantage of the
fish is that there is very little maternal influence on corticosteroid
metabolism during early embryonic development. This is impor-
tant as maternal influences during pregnancy and lactation are
typically confounding issues in experimental models where exog-
enous corticosteroids are administered to pregnant mammals.
While it is known that prolonged exposure to GCs in adult an-
imals causes cardiac remodelling and dysfunction (Walker, 2007)
there have been no studies exploring whether a brief exposure
during embryonic life results in structural or functional changes in
the foetus and whether the effects are carried into the adult. Pre-
vious studies injecting zebrafish embryos with cortisol did
demonstrate a high proportion with significant cardiac structural
defects (Nesan and Vijayan, 2012). In contrast, we saw few embryos
with gross cardiac deformities despite using relatively high doses of
Dex in the bathing water. Our study clearly shows that exposure of
embryos to excess Dex led to a larger moremature embryonic heart
with a higher expression of ventricular myosin heavy chain. These
hearts also had fewer cardiomyocytes despite being larger sug-
gesting cellular hypertrophy. This is plausible given that GCs have
previously been shown to induce hypertrophy in cultured car-
diomyocytes (Ohtani et al., 2009). In adults derived from these Dex-
treated embryos, hearts were larger and heavier than controls.
Fig. 7. Effects of embryonic glucocorticoid receptor manipulation on adult heart gene expression mRNA expression in adult isolated hearts after glucocorticoid receptor (GR)
manipulation with either GR agonist dexamethasone (Dex) [100 mM], or targeted GR knockdown using morpholino (GR Mo). Genes of interest were (A) Glucocorticoid receptor (gr)
(B) Insulin like growth factor (igf), (C) ventricular myosin heavy chain (vmhc), (D) phospholamban (plb), (E) Ryanodine receptor (ryr), (F) sarco-endoplasmic reticulum Ca2þ ATPase
(serca), (G) myocyte enhancer factor 2 c (mef2c), (H) GATA transcription factor 4 (gata4) and (I) Homeobox protein NKX2.5 (nkx2.5). Relative mRNA expression was determined from
isolated hearts at 120 dpf, mean of n ¼ 3 (5 hearts per n) ± SEM, all data analysed compared to control by one-way ANOVA and Dunnett's post hoc test (*p  0.05, **p  0.01,
***p  0.001).
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phy typically seen in mammalian hypertrophy such as sarcomere
reorganisation, altered vascular patterning and interstitial fibrosis
were absent. Unfortunately, the zebrafish heart has a complex and
irregular arrangement of cardiomyocytes such that wewere unable
to obtain a consistent cellular alignment in order to measure car-
diomyocyte cross-sectional area in adult hearts. Therefore, we
cannot fully exclude the possibility that the heart enlargement seen
in adult Dex hearts was in fact due to an excess of non-
cardiomyocyte cells or due to cardiomyocyte hyperplasia. Howev-
er, given our findings in the embryo suggesting cardiomyocyte
hypertrophy we can be more certain that this was also present in
the adult zebrafish heart. In addition, we found increased levels of
vmhc mRNA levels in adult Dex-hearts. Increased levels of vmhc
mRNA (homologous to mammalian b-MHC) have been reported in
a transgenic zebrafish model of cardiac hypertrophy (Chen et al.,
2013) supporting the possibility that Dex adult hearts were
enlarged due to cardiomyocyte hypertrophy.
Calcium handling genes were altered in adult Dex-hearts with
reduced levels of ryr and increased levels of plb with no change in
serca. This combination of changes in calcium cycling genes, if re-
flected in protein expression, would be likely to reduce calciumuptake and release possibly leading to altered contractile function.
Wewere unable to detect changes in Doppler flow patterns in Dex-
treated hearts and there were also no changes in ejection fraction.
This could have been due to a lack of sensitivity of echocardiogra-
phy to detect a change at the whole organ level.
Dex adult hearts demonstrated reduced levels ofmef2cwhich is
known to play an important role in cardiac development (Yu et al.,
2013) and in inducing cardiomyocyte phenotype in cultured human
fibroblasts (Wada et al., 2013). Previous reports also indicate that
mef2c and Gr act cooperatively in controlling gene transcription,
with GR influencing Mef2 activity (Speksnijder et al., 2012). The
mef2 transcription factor family is important in the regulation of
cardiac energy metabolism including cardiac fatty acid oxidation
and maintenance of mitochondrial function (Czubryt and Olson,
2004). Low mef2c mRNA levels could therefore reflect an alter-
ation in a number of cellular processes including proliferative ca-
pacity; control of transcription of GR related genes and cardiac
metabolism.
Benato and colleagues (Benato et al., 2014), using a
glucocorticoid-responsive zebrafish transgenic line found high
expression of their transgene in the cardiac district of 2 dpf embryos
and in the heart of 5 dpf larvae aswell as in adult fish (particularly in
K.S. Wilson et al. / Molecular and Cellular Endocrinology 414 (2015) 120e131130the ventricular epicardium). This is very interesting given the subtle
changes induced by embryonic Dex treatment in our adult hearts.
Over-activation of GR in rodents has also been shown to alter adult
cardiac physiology mainly mediated by conduction defects (Sainte-
Marie et al., 2007). Again this suggests that GC signalling plays a key
role in cardiomyocyte function and remodelling after insults in
teleost fish, as shown in mice (Ren et al., 2012).
5. Study limitations
Much of the work presented in the current work has focused on
GR-mediated actions of GCs. Since GR modulation was the aim of
this study one may assume that alterations in cardiovascular
structure and physiology are as a direct effect of GR-mediated ac-
tions. However, as the ligand for the mineralocorticoid receptor
(MR), the other known receptor for corticosteroids, has not been
identified in the zebrafish and as there appears to be limited
11 bhsd2 mRNA found in the heart (Tokarz et al., 2013); it is likely
that GC stimulates both MR and GR in the zebrafish heart (Cruz
et al., 2013). Therefore, some of our observations, may have resul-
ted from activation of MR. To understand the specific roles played
by each of the receptors, targetedMrmanipulation could be carried
out concurrently with the Gr modulation as previously reported in
the mouse (Ren et al., 2012).
GCs are known to exert genomic effects by binding to, and
activating, the transcription factors MR and GR. However, non-
genomic effects have also been observed in mammals (Stellato,
2004) and more recently in zebrafish (De Marco et al., 2013). The
mechanisms underlying the non-genomic effects are poorly un-
derstood and it is unclear whether non-genomic and genomic ef-
fects interact (De Marco et al., 2013). It is likely that Dex,
particularly at the higher concentration used here [100 mM], is
producing genomic and non-genomic effects since high concen-
trations are more likely to cause receptor saturation allowing free
drug to have non-receptor mediated (non-genomic) effects. The
steroid-binding characteristics of the receptors may also determine
whether genomic or non-genomic effects are involved. A further
interesting aspect, not reported here, is comparison of Mo treat-
ment with treatment with the drug RU486 (a GR and progesterone
receptor (PR) antagonist). We have previously used this drug in
embryonic exposure studies (Wilson et al., 2013), and while many
of the cardiovascular features observed were consistent with those
observed in GR Mo treated embryos we also identified a number of
non-specific effects which limit its use in this setting.
6. Future research
Future research could include the use of a number of recently
published GR transgenic andmutant lines in similar experiments to
those described here. A novel GR reporter line (Benato et al., 2014)
could provide a way of assessing the impact of early life GC
manipulation on expression of GR-related genes in a number of
tissues throughout the embryos including the heart. Tracing these
effects into adulthood would also be possible in this line. The Gr
mutant zebrafish line (gr (s357)), where the transcriptional activity
of GR is blocked (Griffiths et al., 2012; Muto et al., 2013) could also
provide a novel approach to examining the impact of early per-
turbations in GR action on development and function of the car-
diovascular system. This mutant line could also provide amethod of
dissecting the effects of maternal and endogenous GR transcription.
7. Conclusions
We have clearly shown that short term alterations in GC action
during embryogenesis result in long-term alterations in structure,function and genetic composition of the heart. These changes result
in measurable effects on cardiac contractile function. This could
have important implications for human disease in that early life
events could have subtle long term effects on the heart thus pre-
disposing to altered response to injury or stress in adult life.
Gene nomenclature used throughout will be as follows
(unless highlighted in text)
Example, glucocorticoid receptor (GR).
GR, human (Homo sapiens) GR gene isoform, protein designa-
tion GR;
Gr, rodent (Mus musculus, Rattus norvegicus) GR gene isoform;
protein designation GR;
gr zebrafish (Danio rerio) GR gene isoform, protein designation
Gr.
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